Top Gainers: The Best-Performing North American Stocks and What Drove Them

October 8, 2026 | ATN Trade & Finance

Thursday's session produced three distinct types of winners: a biotech takeout, a medical device breakout, and a wave of energy-linked names riding the surge in oil prices past $100. Here is what moved.

Pacira BioSciences (PCRX): +44% — Takeout at a Premium

The session's biggest move was a clean acquisition story. Viatris (VTRS) agreed Thursday to acquire Pacira BioSciences for $1.65 billion in cash, at $36.50 per share — a 44.8% premium to Wednesday's close. Pacira's assets include Exparel and Zilretta, non-opioid pain treatments that generated approximately $746 million in revenue over the 12 months ended June 2026. The deal is expected to close before year-end. JPMorgan upgraded Pacira to Neutral from Underweight and set its target at the deal price of $36.50. With completion now the primary risk rather than business execution, the stock is essentially trading on close probability.

Haemonetics (HAE): +18% — Partnership Expansion and Dual Upgrades

Haemonetics (medical devices, blood management) jumped to its highest level since March 2021 after an SEC filing confirmed that CSL Plasma — one of the largest US plasma collectors — will extend Haemonetics' NexSys PCS technology with Persona PLUS to all of its existing US collection centers, building on an August framework agreement that had been non-exclusive and of undetermined scope. Two analysts moved the same day: Citi upgraded HAE to Buy and raised its price target to $123 from $92, estimating that each 10% market share recaptured in the CSL relationship adds approximately $0.13 to EPS. BTIG raised its target to $130 from $110 (Buy), citing greater-than-expected plasma revenue upside from the wider rollout. The stock closed near $117.94, with an intraday high of $121.

Tanker and Refiner Stocks: Oil as the Driver

With Brent above $104 and tanker traffic through the Strait of Hormuz at a two-month low, oil-linked equities posted broad gains. Okeanis Eco Tankers (ECO) rose +7.27% and Frontline (FRO) gained +6.03%, continuing a YTD run that has added over 60% to both names as Hormuz disruptions force longer routing and push charter rates higher. PBF Energy (PBF), a refiner that benefits from wide crude-to-product spreads at elevated oil prices, rose +6.76%.

Chipotle (CMG) and Accenture (ACN): Momentum Continues

Chipotle (CMG) extended its recent recovery to +6.21% as investors price in continued improvement in comparable restaurant sales — Q1 2026 marked the first positive comp quarter in roughly a year (+0.5%), and Q3 results are expected later this month. Accenture (ACN) gained +5.96%, continuing to ride the momentum from its October 1 Q4 FY2026 earnings beat (revenue $18.68 billion, up 7% in local currency; EPS $3.29, both above consensus), its largest single-day post-earnings gain in recent history.

What this means for investors: Today's gainers split into two categories. The Pacira move is purely structural — takeout premium, deal spread trade. The HAE move is a fundamental re-rating based on an enlarged commercial partnership with a single large customer; analysts are still raising targets, suggesting consensus estimates have not fully caught up. The oil-driven names (ECO, FRO, PBF) are macro proxies: they go as Hormuz goes. If the disruption persists or worsens, these names have further to run; if a diplomatic or military resolution emerges, they will give back gains quickly. CMG and ACN represent the steadier side of the day — companies whose underlying business data is improving and whose stocks are responding accordingly.

Sources:

Top Gainers: The Best-Performing North American Stocks and What Drove Them

Top Gainers: The Best-Performing North American Stocks and What Drove Them

Leave a comment

Your cart